Euglycaemic diabetic ketoacidosis

Disease1 paper1 finding

In silico1

Associations

1

SGLT-2 inhibitor + metformin

upin humans1Moderate certainty

1 study

SGLT-2 inhibitor + metformin is associated with euglycaemic diabetic ketoacidosis in humans (ROR = 335.43).
Humanspharmacovigilance disproportionality analysis relative to other reports
Adverse event reporting signals for SGLT-2 inhibitor-metformin combination therapy: a disproportionality analysis of the FAERS database · Frontiers in endocrinology · 4 Sep 2026

SGLT-2 inhibitor + metformin →

Latest

2

Frontiers in EndocrinologyIn silico19 Sep

Adverse event reporting signals for SGLT-2 inhibitor-metformin combination therapy: a disproportionality analysis of the FAERS database

SGLT2 inhibitors

Diabetes TherapyReview29 Aug

The Role of SGLT2 Inhibitors in the Prevention of Type 2 Diabetes: A Narrative Review of Current Evidence

SGLT2 inhibitors